Clinical Trial Update: Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study) [NA]

View source ↗

Summary

A clinical trial evaluating the addition of venetoclax to busulfan/cyclophosphamide conditioning for high-risk acute myeloid leukemia and myelodysplastic syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Venetoclax (venetoclax)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute Myeloid Leukemia, High-Risk Acute Myeloid Leukemia | NA | Status: RECRUITING